INTRODUCTION
blinded until data analysis was completed. Heart rate and blood pressure were measured before 138 and every 60 minutes after drug intake. Participants were asked to report any physiological intake. This allowed us to examine the onset of the drug affect and make measurements near the 143 time of peak plasma concentrations. In pilot experiments, taking reflex recordings beyond 2 144 hours after drug intake was too fatiguing for the participants. 
H-reflex Recordings

147
H-reflex recordings were obtained in both non-injured and SCI participants. H-reflexes 148 were evoked in the soleus muscle because they are readily elicited at rest, which was important 149 for the SCI participants as they could not produce voluntary contractions. All non-injured 150 participants, and SCI participants who were able to transfer safely, were placed in a supine 151 position on a padded table. Two SCI participants were examined in a reclined position in their 152 powered wheelchair (1M and 4F in Table 1 ). Two surface electrodes (2.2 x 3.3 cm, Kendall Soft- found with a probe electrode (1ms pulse width, return electrode placed over patella). The Canada). All signals were digitized at a rate of 5kHz using Axoscope hardware and software
160
(Digidata 1440 Series, Molecular Devices, Sunnyvale, USA) and stored on a personal computer 161 for offline analysis. H-and M-wave amplitudes were measured as peak-to-peak using custom-written 
226
Thus, the LLR represents a period where most of the sensory synaptic drive to the motoneuron 227 (i.e., EPSP) has subsided and is produced mainly by a depolarization from the CaPIC (Li et al. was used to determine at which time points the zolmitriptan data differed from the placebo data. In some subjects, the peak reduction in Hmax did not occur at 120 minutes after 311 zolmitriptan intake but earlier at 90 minutes (n = 3 control, n = 1 SCI) or 60 minutes (n = 1 312 control, n = 1 SCI). Thus, when plotting the peak decrease in Hmax occurring at either of these 313 time points (60, 90 or 120 minutes), the Hmax as a percentage of pre-drug was even lower at 314 58.9 ± 0.1% for controls and 62.3 ± 0.23% for SCI participants (Fig. 2C) , with the peak decrease 315 in Hmax similar between the two groups (p = 0.78). In 3 preliminary control participants, the 316 dosage of zolmitriptan needed to be at least 10 mg to see a reduction in Hmax given that 5mg, 317 like placebo, did not produce a decrease in Hmax (Fig. 2D) . Finally, as reflected in the was reduced (Fig. 4A) , similar to that seen for the H-reflex in human participants (Fig. 1) .
RESULTS
268
Effects of zolmitriptan on the H-reflex recruitment curve
at 15 minutes after bath application of the drug. (Fig. 4E) . In all 3 363 SCI participants, zolmitriptan reduced the SPR to 56% of its pre-drug value 120 minutes after 364 drug intake, as shown for the SCI participant in Figure 4F (6M, Table 1 ).
DISCUSSION
367
We demonstrated that facilitation of 5HT1B/D receptors with zolmitriptan, but not 
Mechanism of action of Zolmitriptan on soleus H-reflexes
377
In most control and SCI participants (8/13), the H-reflex was reduced at all stimulation 
Effect of Zolmitriptan on sensory transmission likely via 5HT1B/D receptors
418
Zolmitriptan is a commonly prescribed anti-migraine medication that is able to cross the agonists, which all converge to activate Gi-coupled pathways, at individually lower doses to 497 potentially reduce severe side effects after sudden drug withdrawal.
498
Another spinally targeted strategy has recently been proposed by Marsala's group (site 3, Table 1 ). D) Same as in C but for the LLR in 5 of the 7 SCI participants (1M-5M, Table1). 
